HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (HRTX)

130 filings reported holding HRTX - HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share as of Q1 2016.
HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (HRTX) has 97 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 39.8M shares of 183M outstanding shares and own 21.73% of the company stock.
Largest 10 shareholders include FRANKLIN RESOURCES INC (7.52M shares), FMR LLC (5.43M shares), JANUS CAPITAL MANAGEMENT LLC (3.5M shares), Invesco Ltd. (3.15M shares), Partner Fund Management, L.P. (3.07M shares), BAKER BROS. ADVISORS LP (2.91M shares), Cormorant Asset Management, LLC (1.75M shares), Broadfin Capital, LLC (1.47M shares), STATE STREET CORP (1.21M shares), and VANGUARD GROUP INC (1.16M shares).
This table shows the top 97 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.